536 related articles for article (PubMed ID: 27106296)
1. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
[TBL] [Abstract][Full Text] [Related]
2. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
[TBL] [Abstract][Full Text] [Related]
3. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
5. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
6. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis.
Kishi T; Ikuta T; Matsui Y; Inada K; Matsuda Y; Mishima K; Iwata N
Psychol Med; 2019 Apr; 49(5):772-779. PubMed ID: 29909790
[TBL] [Abstract][Full Text] [Related]
7. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
[TBL] [Abstract][Full Text] [Related]
8. A review of second-generation antipsychotic discontinuation in first-episode psychosis.
Miller BJ
J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960
[TBL] [Abstract][Full Text] [Related]
9. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
[TBL] [Abstract][Full Text] [Related]
10. Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis.
Thompson A; Singh S; Birchwood M
Early Interv Psychiatry; 2016 Aug; 10(4):355-61. PubMed ID: 25962446
[TBL] [Abstract][Full Text] [Related]
11. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
[TBL] [Abstract][Full Text] [Related]
12. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
Hui CLM; Honer WG; Lee EHM; Chang WC; Chan SKW; Chen ESM; Pang EPF; Lui SSY; Chung DWS; Yeung WS; Ng RMK; Lo WTL; Jones PB; Sham P; Chen EYH
Lancet Psychiatry; 2018 May; 5(5):432-442. PubMed ID: 29551618
[TBL] [Abstract][Full Text] [Related]
14. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
Andrade C
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767930
[TBL] [Abstract][Full Text] [Related]
16. [Specialised first-episode psychosis services: a systematic review of the literature].
Skalli L; Nicole L
Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
[TBL] [Abstract][Full Text] [Related]
17. The effects of antipsychotic discontinuation or maintenance on the process of recovery in remitted first-episode psychosis patients - A systematic review and meta-analysis of randomized controlled trials.
Béchard L; Desmeules C; Bachand L; Huot-Lavoie M; Corbeil O; Anderson E; Brodeur S; LeBlanc A; Demers MF; Lauzier S; Roy MA
Eur Psychiatry; 2024 Jan; 67(1):e13. PubMed ID: 38250810
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review.
Karson C; Duffy RA; Eramo A; Nylander AG; Offord SJ
Neuropsychiatr Dis Treat; 2016; 12():57-67. PubMed ID: 26792993
[TBL] [Abstract][Full Text] [Related]
19. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
Zipursky RB; Menezes NM; Streiner DL
Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
[TBL] [Abstract][Full Text] [Related]
20. Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.
Chan KK; Chin QP; Tang JY; Longenecker J; Hui CL; Chiu CP; Lam MM; Wong GH; Chen EY
Early Interv Psychiatry; 2011 Nov; 5(4):324-34. PubMed ID: 21521490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]